These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 14991767

  • 1. Cisplatin restores p53 function and enhances the radiosensitivity in HPV16 E6 containing SiHa cells.
    Huang H, Huang SY, Chen TT, Chen JC, Chiou CL, Huang TM.
    J Cell Biochem; 2004 Mar 01; 91(4):756-65. PubMed ID: 14991767
    [Abstract] [Full Text] [Related]

  • 2. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells.
    Tan S, Hougardy BM, Meersma GJ, Schaap B, de Vries EG, van der Zee AG, de Jong S.
    Mol Pharmacol; 2012 May 01; 81(5):701-9. PubMed ID: 22328720
    [Abstract] [Full Text] [Related]

  • 3. Sodium arsenite suppresses human papillomavirus-16 E6 gene and enhances apoptosis in E6-transfected human lymphoblastoid cells.
    Chou RH, Huang H.
    J Cell Biochem; 2002 May 01; 84(3):615-24. PubMed ID: 11813266
    [Abstract] [Full Text] [Related]

  • 4. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou J, Xu G, Meng L, Lu Y, Wang S, Ma D.
    Apoptosis; 2008 Feb 01; 13(2):273-81. PubMed ID: 18060502
    [Abstract] [Full Text] [Related]

  • 5. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
    Koivusalo R, Krausz E, Ruotsalainen P, Helenius H, Hietanen S.
    Cancer Res; 2002 Dec 15; 62(24):7364-71. PubMed ID: 12499281
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The cytotoxicity of chemotherapy drugs varies in cervical cancer cells depending on the p53 status.
    Koivusalo R, Hietanen S.
    Cancer Biol Ther; 2004 Nov 15; 3(11):1177-83. PubMed ID: 15640620
    [Abstract] [Full Text] [Related]

  • 8. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC, DiMaio D.
    Proc Natl Acad Sci U S A; 2000 Nov 07; 97(23):12513-8. PubMed ID: 11070078
    [Abstract] [Full Text] [Related]

  • 9. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
    Piovesan B, Pennell N, Berinstein NL.
    Oncogene; 1998 Nov 05; 17(18):2339-50. PubMed ID: 9811465
    [Abstract] [Full Text] [Related]

  • 10. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.
    Koivusalo R, Krausz E, Helenius H, Hietanen S.
    Mol Pharmacol; 2005 Aug 05; 68(2):372-82. PubMed ID: 15908516
    [Abstract] [Full Text] [Related]

  • 11. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
    Munagala R, Kausar H, Munjal C, Gupta RC.
    Carcinogenesis; 2011 Nov 05; 32(11):1697-705. PubMed ID: 21859835
    [Abstract] [Full Text] [Related]

  • 12. Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells.
    Bai L, Wei L, Wang J, Li X, He P.
    Int J Gynecol Cancer; 2006 Nov 05; 16(2):718-29. PubMed ID: 16681752
    [Abstract] [Full Text] [Related]

  • 13. Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro.
    Hampson L, Kitchener HC, Hampson IN.
    Antivir Ther; 2006 Nov 05; 11(6):813-25. PubMed ID: 17310826
    [Abstract] [Full Text] [Related]

  • 14. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R, Aqil F, Jeyabalan J, Gupta RC.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):536-46. PubMed ID: 25304375
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
    Tung MC, Lin PL, Cheng YW, Wu DW, Yeh SD, Chen CY, Lee H.
    Oncotarget; 2016 May 31; 7(22):32362-74. PubMed ID: 27083050
    [Abstract] [Full Text] [Related]

  • 17. Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology.
    Qi ZL, Huo X, Xu XJ, Zhang B, Du MG, Yang HW, Zheng LK, Li J, Shen ZY.
    Exp Oncol; 2006 Sep 31; 28(3):235-40. PubMed ID: 17080019
    [Abstract] [Full Text] [Related]

  • 18. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D, Aengeneyndt F, Braspenning J, von Knebel Doeberitz M.
    Oncogene; 1996 Sep 05; 13(5):1027-35. PubMed ID: 8806692
    [Abstract] [Full Text] [Related]

  • 19. Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis.
    Butz K, Geisen C, Ullmann A, Spitkovsky D, Hoppe-Seyler F.
    Int J Cancer; 1996 Nov 15; 68(4):506-13. PubMed ID: 8945623
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.